COM902 (A TIGIT Inhibitor) in Subjects With Advanced Malignancies

Clinical trial NCT04354246 · COMPLETED

Trial details

NCT number: NCT04354246
Sponsor: Compugen Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Cancer Ovarian Cancer Lung Cancer Colon Cancer Plasma Cell Neoplasm Multiple Myeloma HNSCC Microsatellite Stable Colorectal Carcinoma MSS-CRC

Start date: 2020-03-31
Primary completion: 2026-04-01
Enrollment: 94

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.